GlaxoSmithKline expected to talk about China probe
July 21, 2013 at 16:17 PM EDT
GlaxoSmithKline Chief Executive Andrew Witty will detail what action the drugmaker is taking in response to allegations of bribery against it in China when he presents quarterly results on Wednesday, sources familiar with the matter said.
